000 01578 a2200445 4500
005 20250517224522.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1437-160X
024 7 _a10.1007/s00296-018-4097-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCea-Calvo, Luis
245 0 0 _aThe beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
_h[electronic resource]
260 _bRheumatology international
_c09 2018
300 _a1735-1740 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aCross-Sectional Studies
650 0 4 _aHealth Knowledge, Attitudes, Practice
650 0 4 _aHumans
650 0 4 _aMedication Adherence
_xpsychology
650 0 4 _aRetrospective Studies
650 0 4 _aSpain
650 0 4 _aSurveys and Questionnaires
650 0 4 _aAssessment of Medication Adherence
700 1 _aRaya, Enrique
700 1 _aMarras, Carlos
700 1 _aSalman-Monte, Tarek C
700 1 _aOrtiz, Ana
700 1 _aSalvador, Georgina
700 1 _aMonteagudo, Indalecio
700 1 _aCarmona, Loreto
700 1 _aFernandez, Sabela
700 1 _aArteaga, Maria J
700 1 _aCalvo-Allén, Jaime
773 0 _tRheumatology international
_gvol. 38
_gno. 9
_gp. 1735-1740
856 4 0 _uhttps://doi.org/10.1007/s00296-018-4097-y
_zAvailable from publisher's website
999 _c28585975
_d28585975